News

Vaxxinova acquires Epitopix

Vaxxinova acquires Epitopix Vaxxinova, an EW-group company with core business focusing on animal health, has concluded an agreement to acquire 100% of the shares in Epitopix, a US based animal health company specialized in poultry and livestock biologicals and founder of SRP® technology. The transaction was concluded by February 28, 2018. Epitopix is a part of […]
Read more →

New at Vaxxinova diagnostics

PCR profile PCV2/PCV3 – At Vaxxinova, a new real-time PCR assay for the simultaneous detection of PCV2 and PCV3 could be established. The PCR has a high analytical sensitivity and specificity. Our results confirm the presence of PCV3 in Germany. Frequently, double infections of PCV2 and PCV3 have been detected, especially in cases of PMWS […]
Read more →

Vaxxinova, headquartered in The Netherlands, acquires Laboratório Biovet

Vargem Grande Paulista, São Paulo, February 1, 2018. Vaxxinova, a subsidiary of the EW Group, has acquired Laboratório Biovet, a Brazilian company with 60 years of commitment to the animal health industry. Biovet was founded in 1957 by veterinarian René Corrêa, and has remained a family-owned company since then. The company is strongly positioned in […]
Read more →

“Laboratory meets practice” successful Vaxxinova Symposium

This year’s symposium took place on November 28th at the hotel Heidegrund in Garrel and on November 29th in the BioCity Leipzig. The events were well attended by a total of 86 participants. Speakers at both locations were Prof. Bernd Kaspers of the LMU München, the “Pig whisperer” Dr. Kees Scheepens and Dr. Adrian Lührs […]
Read more →